Experimental cancer drug could streamline standard tuberculosis treatment and prevent post-TB lung disease, study suggests

Experimental cancer drug could streamline standard tuberculosis treatment and prevent post-TB lung disease, study suggests

An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, investigators report.

John Green teaches that ‘Everything is Tuberculosis’ in new nonfiction book

John Green, author of “The Fault in Our Stars” and “Looking for Alaska,” launched a new non-fiction book entitled “Everything is Tuberculosis,” which tells the history of the world’s most infectious disease: tuberculosis.  Tuberculosis (TB) killed about a million people in 2023 alone, a statistic most people find bewildering, given how far removed TB has been from a majority of the world. As Green puts it, the world sees it as a “disease of pove…